Martin-Loeches, Ignacio
Leone, Marc
Article History
Received: 1 May 2026
Revised: 11 May 2026
Accepted: 17 May 2026
First Online: 25 August 2026
Declarations
Ethics approval and consent to participate: Not applicable. This manuscript is a narrative review and does not involve human participants, patient data, or experimental interventions requiring ethical approval.
Consent for publication: Not applicable.
Competing interests: Ignacio Martin-Loeches reports personal fees and/or non-financial support from Thermo Fisher Scientific, bioMérieux, MSD, Gilead Sciences, Mundipharma, and Pfizer, outside the submitted work. Marc Leone reports receiving speaking and lecture fees from Edwards Lifesciences Corporation, Grifols Inc, Shionogi Inc, and Viatris, and consulting or advisory fees from Previa SPA, outside the submitted work.